THE POTENTIAL OF SIRNA ENCAPSULATED BY NANOPARTICLE AS SILENCING AGENT FOR SFLT-1 AND NRF-2: Effective Therapy Inovation Against Preeclampsia. JIMKI 2022, 9 (3), 34-41. https://doi.org/10.53366/jimki.v9i3.433.